| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.13M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BCLI returned +50.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +78.2% |
| 1 year | +50.8% |
| 5 years | -98.1% |
| 10 years | -97.3% |
| All-time high | $627.75 (Mar 2005) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BCLI would be worth today ›No. Brainstorm Cell Therapeutics Inc. has not paid a dividend in the past 12 months.
Brainstorm Cell Therapeutics Inc. is part of the Healthcare sector.
Brainstorm Cell Therapeutics Inc. has a market cap of 10.81M USD, based on the latest quote.
